AI Tool Shows Promise in Improving Colonoscopy Adherence
A study has shown artificial intelligence virtual navigation to be a promising tool to improve colonoscopy completion rates, with high patient acceptance.
A study has shown artificial intelligence virtual navigation to be a promising tool to improve colonoscopy completion rates, with high patient acceptance.
Momelotinib led to “superior” symptom and spleen responses and transfusion independence rates compared to danazol in thrombocytopenic myelofibrosis.
A breast cancer breakthroughs fundraising event, where you’ll learn about the progress our dedicated physician-scientists have made for today’s patients and the discoveries they’re pursuing…
Advancements in Genitourinary Cancers: From Guidelines to Patient-Centered Care
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.
The sNDA is supported by data from the phase 3 LAURA trial.
An abstract is unavailable.
The approval was based on data from the phase 2/3 IMerge study.
As part of its Speaking Out series, Patrick Wagner, MD, discusses safety concerns regarding oncolytic viral therapy.
An abstract is unavailable.